Latest Information Update: 20 Jun 2001
Price : $50 *
At a glance
- Originator Unknown
- Developer Kyorin Pharmaceutical
- Class Cytostatic antibiotics
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 20 Jun 2001 Discontinued-Preclinical for Cancer in Japan (Unknown route)
- 12 Jan 1996 The ATC and EPhMRA codes for S 116 are L01 and L1, respectively.